Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Treasury Shares (2016 - 2025)

Surgery Partners' Treasury Shares history spans 12 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 36.24% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, up 36.24%, while the annual FY2025 figure was $1.2 million, 36.24% up from the prior year.
  • Treasury Shares for Q4 2025 was $1.2 million at Surgery Partners, up from $886834.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.7 million in Q4 2021 and bottomed at $730850.0 in Q4 2023.
  • The 5-year median for Treasury Shares is $995413.0 (2022), against an average of $1.1 million.
  • The largest annual shift saw Treasury Shares plummeted 39.87% in 2022 before it surged 36.24% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $1.7 million in 2021, then tumbled by 39.87% to $995413.0 in 2022, then fell by 26.58% to $730850.0 in 2023, then grew by 21.34% to $886834.0 in 2024, then skyrocketed by 36.24% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Treasury Shares are $1.2 million (Q4 2025), $886834.0 (Q4 2024), and $730850.0 (Q4 2023).